Title : S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.

Pub. Date : 2014

PMID : 25031751






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. Cisplatin proteasome 26S subunit, non-ATPase 1 Homo sapiens
2 To evaluate the efficacy and toxicity of S-1 monotherapy in patients with advanced gastric cancer after failure of first line cisplatin and fluorouracil combination (CF). Cisplatin proteasome 26S subunit, non-ATPase 1 Homo sapiens
3 In conclusion, S-1 monotherapy provided a mild response rate and overall survival, and a favorable toxicity profile in the second line setting after the first line failure to cisplatin and fluorouracil combination. Cisplatin proteasome 26S subunit, non-ATPase 1 Homo sapiens